<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Risk assessment on FinanClub</title>
    <link>https://finan.club/tags/risk-assessment/</link>
    <description>Recent content in Risk assessment on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Sat, 30 Mar 2024 09:04:47 +0000</lastBuildDate><atom:link href="https://finan.club/tags/risk-assessment/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>UPST</title>
      <link>https://finan.club/us/upst/</link>
      <pubDate>Sat, 30 Mar 2024 09:04:47 +0000</pubDate>
      
      <guid>https://finan.club/us/upst/</guid>
      <description>score:45
Chances: Upstart Holdings, Inc. has recently partnered with Liberty Savings Bank for Personal Lending, indicating potential growth in their customer base and revenue. Despite recent declines in the stock price, there are still opportunities for Upstart Holdings, Inc. to bounce back and recover.</description>
    </item>
    
    <item>
      <title>DOC</title>
      <link>https://finan.club/us/doc/</link>
      <pubDate>Sat, 30 Mar 2024 09:02:33 +0000</pubDate>
      
      <guid>https://finan.club/us/doc/</guid>
      <description>score:58
Chances: Healthpeak Properties, Inc. is positioned well to capitalize on the secular trends of the healthcare real estate industry. The merger with Physicians Realty Trust can lead to increased growth and opportunities for Healthpeak Properties, Inc. Risks: The recent dip in net income for Physicians Realty Trust may pose a short-term risk.</description>
    </item>
    
    <item>
      <title>CAH</title>
      <link>https://finan.club/us/cah/</link>
      <pubDate>Thu, 01 Feb 2024 09:06:00 +0000</pubDate>
      
      <guid>https://finan.club/us/cah/</guid>
      <description>score:-141
Chances: Cardinal Health&amp;rsquo;s acquisition of Specialty Networks for $1.2 billion shows its commitment to investing in the specialty pharmacy business, which is a positive sign for potential growth and expansion. The company&amp;rsquo;s strong performance in the Pharmaceutical segment in the second-quarter fiscal 2024 indicates stability and potential for continued growth.</description>
    </item>
    
  </channel>
</rss>
